Rejeesh Menon, MD

Academic internal medicine physician and clinical AI physician-builder. Clinical Assistant Professor, Elson S. Floyd College of Medicine, Washington State University.

Richland, Washington, United States. rejeeshmenon85@gmail.com, rejeesh.menon@wsu.edu. U.S. permanent resident (EB-1A, Extraordinary Ability). No sponsorship required.

Formatted version

Summary

Academic internal medicine physician and clinical assistant professor who also builds the software his clinics run on. Ten years of inpatient medicine in U.S. community hospitals; a translational research background that took an amino-acid formulation from the Ussing chamber to a Nestle-licensed product; a seven-clinic dermatology group in India that serves as a live environment for shipping and testing clinical software. Builds solo with Claude Code CLI, writing the prompts and owning the clinical logic, the human-in-the-loop boundaries, the safety rules for what generative output may say to a patient, and the compliance decisions.

Target roles: Clinical AI evaluation and safety roles; Medical director of clinical AI; AI research faculty; Technical cofounder.

Clinical AI and Software

Each system was specified, built and shipped solo, with AI-assisted development (Claude Code CLI and agentic tooling) and no other engineers. Rejeesh writes the prompts and owns the clinical logic, the autonomy boundaries and the compliance decisions.

Authorship across projects, oldest to newest: Designed and built -> Built and shipped -> Built and shipped -> Built and maintains.

SuperHuman: Clinical-intelligence tool for GLP-1 and metabolic care

Status: In pilot, 2026. Role: Designed and built. Stack: Next.js, Supabase, PostgreSQL, Vultr, AWS, HIPAA-conscious architecture.

DermaVue Clinic OS: Patient engagement and CRM platform

Status: Live across seven clinics, 2025 to present. Role: Built and shipped. Stack: NestJS, Next.js, Python, Twenty CRM, Chatwoot, WhatsApp Business API, Docker on Linux VPS.

DermaVue Commerce: Online store for the group's skincare line

Status: Shipped, 2026. Role: Built and shipped. Stack: Astro, Vendure, PostgreSQL.

dermavue.com: Public clinical web platform

Status: Live. Role: Built and maintains. Stack: WordPress (PHP, hand-coded templates), Astro, schema.org JSON-LD, Search-indexing automation. URL: https://dermavue.com

The safety-design decisions below are self-reported. Unlike the licenses and publications elsewhere on this page, no external body yet certifies clinical-AI autonomy-boundary design of this kind.

Technical Capabilities

AI-assisted development
Claude Code CLI; Agentic workflows
Software
TypeScript and Node (Next.js, NestJS, Astro); PHP (WordPress); Python; PostgreSQL; Docker; Linux VPS (Hetzner, Vultr); AWS
Health data and compliance
HL7 FHIR R4 and SMART on FHIR; HIPAA program design (BAA boundaries, synthetic-data development, decision-support design built to meet the FDA's non-device clinical decision support criteria); Twenty CRM, Chatwoot, WhatsApp Business API
Clinical systems (daily attending user)
Epic (2013 to present); Meditech (2016 to present); Cerner (2018 to 2021)
Research methods
Ussing-chamber electrophysiology; Ion-transport and radioisotope flux studies; Confocal microscopy; Immunohistochemistry; BrdU labeling; SPSS; Origin

Clinical Practice

Attending Physician, Hospital Medicine, and Clinical Assistant Professor

Pullman Regional Hospital and WSU Elson S. Floyd College of Medicine, Pullman, WA. 2022 to present.

Hospitalist and Associate Director, Inpatient Rehabilitation Unit

Lourdes Medical Center, Pasco, WA. 2019 to 2025.

Hospitalist

Confluence Health, Wenatchee and Moses Lake, WA. 2016 to 2019.

Hospice Physician (part-time)

Chaplaincy Health Care, Richland, WA. 2022 to present.

Entrepreneurship

Co-Founder and Director, DermaVue Skin & Hair Clinics

Kerala and Tamil Nadu, India. 2017 to present.

Co-Founder and Director, EBC Pharmaceuticals

India. 2017 to present.

Research

Postdoctoral research scholar at the University of Florida (2011 to 2013). The team's intestinal-transport work produced enterade, an amino-acid rehydration formulation funded by NASA/NSBRI, licensed worldwide to Nestle Health Science (2018), and studied at Harvard, Dana-Farber, the U.S. Army and the University of Kentucky. Co-investigator on the first randomized trial in chikungunya arthritis (120 patients, GCP conditions), now cited in UpToDate and national guidelines.

Postdoctoral Research Scholar

University of Florida, Department of Radiation Oncology, Gainesville, FL. 2011 to 2013.

223 citations, h-index 6, i10-index 6, 96 citations since 2021 (Google Scholar, September 2026).

Selected publications

  1. Kanu EO, Kim DK, Menon R, Burke C, Vicknair N. Euglycemic ketoacidosis after the addition of a glucagon-like peptide-1 receptor agonist: a case report. Annals of Internal Medicine: Clinical Cases. 2024;3(6):e230565. doi:10.7326/aimcc.2023.0565. 5 citations.
  2. Yin L, Vijaygopal P, MacGregor GG, Menon R, et al. Glucose stimulates calcium-activated chloride secretion in small intestinal cells. American Journal of Physiology - Cell Physiology. 2014;306(7):C687-C696. doi:10.1152/ajpcell.00174.2013. PMID 24477233. 44 citations. F1000Prime recommended.
  3. Padmakumar B, Jayan JB, Menon RMR, et al. Comparative evaluation of four therapeutic regimes in chikungunya arthritis: a prospective randomized parallel-group study. Indian Journal of Rheumatology. 2009;4(3):94-101. doi:10.1016/S0973-3698(10)60189-6. 70 citations. First randomized trial in chikungunya arthritis; equal contribution.

Education and Credentials

Board certification and licensure

Teaching and Recognition